Nalls Sherbakoff Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$14.5K Hold
300
0.01% 300
2025
Q3
$14.2K Hold
300
0.01% 302
2025
Q2
$14.5K Hold
300
0.01% 302
2025
Q1
$16.6K Buy
+300
New +$16.2K 0.01% 263
2023
Q4
$14.9K Hold
300
0.01% 254
2023
Q3
$16.1K Hold
300
0.02% 241
2023
Q2
$15.3K Hold
300
0.02% 247
2023
Q1
$16.2K Buy
+300
New +$14.6K 0.02% 247
2018
Q4
$13K Buy
+300
New +$13.2K 0.02% 250

Other funds holding SNY

Nalls Sherbakoff Group's SNY Position: Q4 2025 in Review

Nalls Sherbakoff Group held its Sanofi (SNY) position steady in Q4 2025 at 300 shares worth $14.5K. The position accounts for 0.01% of the portfolio, ranked #300.

Nalls Sherbakoff Group first reported a position in SNY in Q4 2018 and has held it in 9 quarters since. The position peaked at $16.6K in Q1 2025. 755 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Nalls Sherbakoff Group held 300 shares of Sanofi worth $14.5K as of Q4 2025.
  • Nalls Sherbakoff Group left its Sanofi share count unchanged in Q4 2025.
  • Sanofi made up 0.01% of Nalls Sherbakoff Group's portfolio in Q4 2025, its #300 holding.
  • Nalls Sherbakoff Group first reported a position in Sanofi in Q4 2018 and has held it in 9 quarters since.
  • Nalls Sherbakoff Group's Sanofi position peaked at $16.6K in Q1 2025.
  • 755 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2025, filed 12 Mar 2026.